SCHEMBL9194575

SCHEMBL9194575

Cc1cccn2nc(-c3ccccc3)c(C=O)c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 1/20 0.44
▸ ALDH1A1 P00352 9/20 0.38
▸ KDM4E B2RXH2 6/20 0.38
▸ NPC1 O15118 5/20 0.38
▸ NPSR1 Q6W5P4 4/20 0.38
▸ RAB9A P51151 4/20 0.38
▸ ATM Q13315 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ GLA P06280 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ PTGS2 P35354 1/20 0.37
▸ MEN1 O00255 4/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ MAPT P10636 3/20 0.36
▸ LMNA P02545 3/20 0.36
▸ USP2 O75604 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ RECQL P46063 1/20 0.36
▸ HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formamide SCHEMBL23320546 0.81 MAPK14 (0.46) MAPK14ALDH1A1KDM4ENPC1NPSR1
SCHEMBL8811759 0.75 ADORA2A (0.45) MAPK14ALDH1A1PTGS2LMNAMAPK1
SCHEMBL9753063 0.73 EGFR (0.39) MAPK14ALDH1A1NPSR1PTGS2MEN1
SCHEMBL5062838 0.72 HTR6 (0.46) ALDH1A1KDM4ENPC1NPSR1RAB9A
SCHEMBL10554600 0.72 PTGS2 (0.44) ALDH1A1GAAPTGS2KMT2AL3MBTL1
SCHEMBL7915882 0.71 MEN1 (0.59) ALDH1A1KDM4ENPC1RAB9APTGS2
SCHEMBL19209454 0.70 ALDH1A1 (0.43) ALDH1A1KDM4ENPC1NPSR1RAB9A
SCHEMBL5062762 0.69 PTGS2 (0.46) ALDH1A1KDM4ENPC1NPSR1RAB9A
SCHEMBL9752969 0.68 MAPK14 (0.47) MAPK14ALDH1A1PTGS2KMT2ALMNA
SCHEMBL6987562 0.67 MAPK14 (0.58) MAPK14ALDH1A1KDM4ENPC1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0299209-B1 Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1995-09-13 — — EP disclosed
US-5296490-A Pharmaceutically useful pyrazolopyridines FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-03-22 — — US disclosed
US-5179103-A Diuretics, hypotensive agents FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1993-01-12 — — US disclosed
US-5102878-A Treating psychological, bone, cardiovascular, blood disorders FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-07 — — US disclosed
US-5102869-A Urogenital disorders FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-07 — — US disclosed
US-5087629-A Diuretics, hypotensive agents; cardiotonic agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-02-11 — — US disclosed
US-4994453-A Treating asthma, diabetes, obesity, immunosuppression FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-02-19 — — US disclosed
US-4925849-A DIURETICS, HYPOTENSIVE AGENTS, CARIOTONIC AGENTS AND ANTIEDEMIC AGENTS FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1990-05-15 — — US disclosed
EP-0299209-A2 Pyrazolopyridine compound and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-01-18 — — EP disclosed
Send feedback